Patient Reported Financial Toxicity in AML & MPN
Third in ASH 2018 Series
by David Wallace
Dr. Michael Grunwald is the Director, Leukemia Division, Department of Hematologic Oncology and Blood Disorders at Levine Cancer Institute in Charlotte, NC. Dr. Grunwald and David Wallace, PV Reporter, discuss multiple topics during ASH 2018 conference.
The ASH abstracts we discussed can be found here – Patient Reported Financial Toxicity in Acute Leukemia and Real-World Risk Assessment and Treatment of Patients with Myelofibrosis at Community Oncology Practices in the United States.
